How a 6-Year-Old Beat Leukemia Without Chemo

A Christmas No One Thought Was Possible
Just one year ago, Christmas looked very different for the Ailinger family. Five-year-old Bryn Ailinger was spending the holidays isolated in a pediatric cancer ward after being diagnosed with a rare and aggressive form of leukemia that did not respond to standard chemotherapy. Today, she’s home, thriving, and celebrating Christmas like a healthy 6-year-old should.

When Traditional Treatment Wasn’t Enough
Bryn was diagnosed with precursor B-cell acute lymphoblastic leukemia carrying a mutation so aggressive that chemotherapy and surgery offered little hope. Her father, Justin Ailinger, remembers fearing he might lose his daughter within months. Faced with limited options, Bryn’s medical team at Roswell Park introduced the family to a groundbreaking alternative: CAR T-cell therapy.

A Nobel Prize–Winning Breakthrough
CAR T-cell therapy works by reengineering a patient’s own immune cells to recognize and destroy cancer. Doctors extract T cells from the blood, genetically modify them in a specialized lab, multiply them by the millions, and infuse them back into the patient. The result can be life-changing—and in Bryn’s case, lifesaving.

Why Doctors Are Rethinking Chemotherapy
Physicians at Roswell Park say CAR T-cell therapy is not only highly effective but far less toxic than traditional chemotherapy, especially for children. Pediatric oncologists emphasize that improving long-term quality of life matters just as much as survival—something immune-based therapies are uniquely positioned to deliver.

From One Child’s Miracle to Many
Today, Bryn’s leukemia remains undetectable. Doctors report that more than 80 percent of patients treated with CAR T-cell therapy see their cancer disappear. Researchers are now working to expand the treatment to additional childhood cancers, including brain tumors and solid tumors.

A Season Reclaimed
Leukemia stole one Christmas from Bryn—but science gave her many more.